{
    "title": "Biogen to bulk up rare disease treatments with $7 billion Reata acquisition",
    "url": "https://www.dailymail.co.uk/wires/ap/article-12348739/Biogen-bulk-rare-disease-treatments-7-billion-Reata-acquisition.html",
    "date": "2023-07-28",
    "keywords": [
        "biogen",
        "treatment",
        "share",
        "reata",
        "deal",
        "year",
        "disease",
        "viehbacher",
        "companys",
        "developer",
        "cash",
        "end",
        "ataxia",
        "value",
        "sclerosis",
        "price",
        "plano",
        "metabolism",
        "inflammation",
        "disorder",
        "friedreichs",
        "acquisition",
        "techfidera",
        "tysabri",
        "atrophy",
        "spinraza",
        "drugmaker",
        "leqembi",
        "inc",
        "headquarters",
        "march",
        "cambridge",
        "mass",
        "ceo",
        "christopher",
        "statement",
        "experience",
        "market",
        "skyclarys",
        "gene",
        "defect",
        "johns",
        "vision",
        "hearing",
        "loss",
        "trouble",
        "heart",
        "wheelchair",
        "pipeline",
        "november",
        "launch",
        "aduhelm",
        "tuesday",
        "company",
        "quarter",
        "trajectory",
        "heard",
        "hasnt",
        "shareholder",
        "capital",
        "way",
        "commensurate",
        "premarket",
        "trading",
        "friday",
        "stock"
    ],
    "category": [
        "wires",
        "ap"
    ]
}